Curelab Oncology
Dedham, US · Founded 2019 · Delaware corporation
Curelab Oncology develops anti-cancer drugs with a focus on gene therapy and immuno-oncology, taking programs from early discovery through clinical development. It is a biotech company operating in the oncology drug development space.
Founders & leadership
Curelab Oncology was founded in 2019 by Alex Shneider and Alexander Shneider.
AS
Alex ShneiderCo-founder
AS
Alexander ShneiderFounder & CEO, BoD Chairman
CL
Charles LeggCOO
JP
Jason PayneNamed on SEC filing
VG
Vlad GabaiVP of R&D
Board
AM
Anatoli MeriinBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2022
▶$3MraisedDec 2022 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles LeggExecutive Officer
- Alex ShneiderExecutive Officer
- Jason PayneExecutive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $10K
- Proceeds to insiders
- $100K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Curelab Oncology do?
- Curelab Oncology develops anti-cancer drugs with a focus on gene therapy and immuno-oncology, taking programs from early discovery through clinical development. It is a biotech company operating in the oncology drug development space.
- Who founded Curelab Oncology?
- Curelab Oncology was founded by Alex Shneider, Alexander Shneider in 2019.
- How much funding has Curelab Oncology raised?
- Curelab Oncology has disclosed $3M raised across 1 round.
- Where is Curelab Oncology headquartered?
- Curelab Oncology is headquartered in Dedham, US.